The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria

European Journal of Clinical Pharmacology

Volumn 59, Issue 7, 2003, Pages 545-552

  McGready, R ^a,b,c   Stepniewska, K ^b,c   Edstein, M D ^d   Cho, T ^a   Gilveray, G ^a   Looareesuwan, S ^b   White, N J ^b,c   Nosten, F ^a,b,c  

^a SHOKLO MALARIA RESEARCH UNIT   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d AUSTRALIAN ARMY MALARIA INSTITUTE   (Australia)

Author keywords

Malaria; P. falciparum; Pregnancy

Indexed keywords

ARTESUNATE; ATOVAQUONE PLUS PROGUANIL; CYCLOGUANIL;

ADULT; ARTICLE; CLINICAL ARTICLE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG TOLERABILITY; FEMALE; HUMAN; MALARIA FALCIPARUM; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; SIDE EFFECT; THIRD TRIMESTER PREGNANCY;

ACUTE DISEASE; ANTIMALARIALS; ARTEMISININS; ATOVAQUONE; CHLOROGUANIDE; DRUG COMBINATIONS; DRUG RESISTANCE, MULTIPLE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALARIA, FALCIPARUM; NAPHTHOQUINONES; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; SESQUITERPENES; THAILAND;

EID: 0242320357     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-003-0652-9     Document Type: Article

References (28)

1. Brockman A, Price RN, van Vugt M, Heppner DG, Walsh DS, Sookto P, Wimonwattrawatee T, Looareesuwan S, White NJ, Nosten F (2000) Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive artesunate-mefloquine use. Trans R Soc Trop Med Hyg 94:537-544
2. McGready R, Brockman A, Cho T, Cho D, van Vugt M, Luxemburger C, Chongsuphajaisiddhi T, White NJ, Nosten F (2000) Randomized comparison of mefloquine-artesunate combination versus quinine in treatment of multi-drug resistant falciparum malaria in pregnancy. Trans R Soc Trop Med Hyg 94:689-693
3. McGready R, Cho T, Khan Keo N, Thwai KL, S L, White NJ, Nosten F (2001) Artemisinin antimalarials in pregnancy: a prospective treatment study of 539 episodes of multidrug-resistant P. falciparum. Clin Infec Dis 33:2009-2016
4. Looareesuwan S, Viravan C, Webster HK, Kyle DE, Hutchinson DB, Canfield CJ (1996) Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am J Trop Med Hyg 54:62-66
5. Product information, Malarone (atovaquone and proguanil hydrochloride). Physician's Desk Reference 2001; Medical Economics Company, Inc. Montvale (NJ), USA
6. van Vugt M, Edstein MD, Proux S, Lay K, Ooh M, Loorareesuwan S, White NJ, Nosten F (1999) Absence of an interaction between artesunate and atovaquone-proguanil. Eur J Clin Pharmacol 55:469-474
7. van Vugt M, Leonardi E, Phaipun L, Slight T, Thway KL, McGready R, Brockman A, Villegas L, Looareesuwan S, White NJ, Nosten F (2002) Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone- proguanil. Clin Infect Dis 35:1498-1504
8. McGready R, Khan Keo N, Villegas L, White NJ, Looareesuwan S, Nosten F (2003) Artesunate-atovaquone-proguanil rescue treatment of multidrug resistant falciparum malaria in pregnancy: a preliminary report. Trans R Soc Trop Med Hyg (in press)
9. Nosten F, ter Kuile F, Maelankirri L, Decludt B, White NJ (1991) Malaria during pregnancy in an area of unstable endemicity. Trans R Soc Trop Med Hyg 85:424-429
10. Price RN, Nosten F, Luxemburger C, van Vugt M, Phaipun L, Chongsuphajaisiddhi T, White NJ (1997) Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria. Trans R Soc Trop Med Hyg 91:574-577
11. Brockman A, Paul RE, Anderson TJ, Hackford I, Phaiphun L, Looareesuwan S, Nosten F, Day KP (1999) Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand. Am J Trop Med Hyg 60:14-21
12. Nosten F, McGready R, Simpson JA, Thwai KL, Balkan S, Cho T, Hkirijaroen L, Looareesuwan S, White NJ (1999) Effects of Plasmodium vivax malaria in pregnancy. Lancet 354:546-549
13. Rolan PE, Mercer AJ, Weatherley BC, Holdich T, Meire H, Peck RW, Ridout G, Posner J (1994) Examination of some factors responsible for a food-induced increase in absorption of atovaquone. Br J Clin Pharmacol 37:13-20
14. Shanks GD, Edstein MD, Chedester AL, Smith CD, Corcoran KD, Ngampochjana M, Hansukjariya P, Sattabongkot J, Webster HK (1994) Proguanil plus sulfamethoxazole is not causally prophylactic in the Macaca mulatto-Plasmodium cynomolgi model. Am J Trop Med Hyg 50:641-645
15. Taylor RB, Moody RR, Ochekpe NA (1987) Determination of proguanil and its metabolites cycloguanil and 4-chlorophenylbiguanide in plasma, whole blood and urine by HPLC. J Chromatogr 416:394-399
16. Lindstrom ML, Bates DM (1990) Nonlinear mixed effects models for repeated measures data. Biometrics 46:673-687
17. McGready R, Cho T, Samuel, Villegas L, Brockman A, van Vugt M, Looareesuwan S, White NJ, Nosten F (2001) Randomized comparison of quinine-clindamycin versus artesunate in the treatment of falciparum malaria in pregnancy. Trans R Soc Trop Med Hyg 95:651-656
18. Hussein Z, Eaves J, Hutchinson D, Canfield C (1997) Population pharmacokinetics of atovaquone in patients with acute malaria caused by Plasmodium falciparum. Clin Pharm Therapeut 61:518-530
19. Hussein Z, Eaves CJ, Hutchinson DB, Canfield CJ (1996) Population pharmacokinetics of proguanil in patients with acute P. falciparum malaria after combined therapy with atovaquone. Br J Clin Pharmacol 42:589-597
20. Sabcharoen A, Attanath P, Phanuaksook P, Chanthavanich P, Poonpanich Y, Mookmanee D, Chongsuphajaisiddhi T, Sadler BM, Hussein Z, Canfield CJ, Hutchinson DB (1998) Efficacy and pharmacokinetics of atovaquone and proguanil in children with multidrug-resistant Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 92:201-206
21. Ward SA, Helsby NA, Skjelbo E, Brosen K, Gram LF, Breckenridge AM (1991) The activation of the biguanide antimalarial proguanil co-segregates with the mephenytoin oxidation polymorphism - a panel study. Br J Clin Pharmacol 31:689-692
22. Edstein MD, Shanks GD, Teja-Isavadharm P, Rieckmann KH, Webster HK (1994) Oxidative activation of proguanil and dapsone acetylation in Thai soldiers. Br J Clin Pharmacol 37:67-70
23. Wangboonskul J, White NJ, Nosten F, ter Kuile F, Moody RR, Taylor RB (1993) Single dose pharmacokinetics of proguanil and its metabolites in pregnancy. Eur J Clin Pharmacol 44:247-251
24. Wattanagoon Y, Taylor RB, Moody RR, Ochekpe NA, Looareesuwan S, White NJ (1987) Single dose pharmacokinetics of proguanil and its metabolites in healthy subjects. Br J Clin Pharmacol 24:775-780
25. Karbwang J, White NJ (1990) Clinical pharmacokinetics of mefloquine. Clin Pharmacokinet 19:264-279
26. McGready R, Stepniewska K, Seaton E, Cho T, Cho D, Ginsburg A, Edstein MD, Ashley E, Looareesuwan S, White NJ, Nosten F. (2003) Pregnancy and use of oral contraceptives reduces the biotransformation of proguanil to cycloguanil. Eur J Clin Pharm (this issue)
27. Jones K, Ward SA (2002) Biguanide-atovaquone synergy against Plasmodium falciparum in vitro. Antimicrob Agents Chemother 46:2700-2703
28. White NJ, van Vugt M, Ezzet F (1999) Clinical pharmacokinetics and pharmacodynamics of artemether-lumefantrine. Clin Pharmacokinet 37:105-125